Research
Search
Close
ZHENG Shui'er
- Chief Physician, Graduate Supervisor
- Department: Oncology
- Research Area: Oncology
- Research Interests: Bone and soft tissue, Sarcoma
- Contact: zse78106@qq.com
- MD from Zhejiang University School of Medicine, 2007
- Zheng Shuier#,et al. N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitinate on of BRMS1.EbioMedicine, 2020, 59:102955.
- Zheng Shuier#,et al. FAT1 and MSH2 are predictive prognostic markers for Chinese osteosarcoma patients following chemotherapeutic treatment. Journal of Bone and Mineral Research, 2022, 37(5):885-895.
- Zheng Shuier#,et al. SequentialChemotherapy and Immunotherapy Produce Sustained Response in Osteosarcoma With High Tumor Mutational Burden. Frontiers in Endocrinology,2021,12: 625226
- 01/01/2023-12/31/2026
- National Natural Science Foundation of China , ¥520,000, 82272835
- High-throughput screening to elucidate the molecular mechanism of adriamycin resistance in TRIM7-dependent and independent osteosarcoma
- Role: Principal Investigator
